Eckert & Ziegler stock slips as Berenberg keeps Buy
Published on 08/26/2026 at 17:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Eckert & Ziegler SE (DE0005659700) traded at EUR 13.13 on August 26, 2026, with a market cap of EUR 824.76 million and a 5-day move of -2.46% as investors digested a fresh Berenberg note that kept its Buy rating and left the target at EUR 23.
Buy rating holds
A MarketScreener report published on August 26, 2026 said Christian Ehmann at Berenberg kept a Buy rating on the German medical technology group and held the price target at EUR 23. The same report showed the shares at EUR 13.12 in estimated Tradegate trading and a year-to-date change of -14.29%.
The setup leaves a wide gap between the target and the current quote. For investors, that gap matters more than the one-day move.
Latest reported figures
The company reported H1 2026 results for the six months ended June 30, 2026, a period that keeps the numbers in the current window for this article. The report context also points to a Q2 2026 earnings call on August 13, 2026.
That matters because the most recent half-year period is the best anchor for operating momentum. The current estimate view on the same portal shows 3 analysts, an average target of EUR 21.60, and a last close of EUR 13.18.
Operations and outlook
Recent coverage around the H1 2026 call highlighted the radio-pharma and isotopes businesses, which remain central to the group's medical, scientific, and industrial portfolio. The company had 1,105 employees in the portal profile and a calendar entry for third-quarter 2026 results on November 12, 2026.
That mix of a Buy rating, a EUR 23 target, and a current quote in the low EUR 13 area keeps valuation at the center of the debate.
Product focus
Eckert & Ziegler's business spans brachytherapy products, isotope sources, calibration tools, and radiopharma components used in nuclear medicine and industrial measurement. Its portal profile describes three segments: Radiotherapy, Isotope Products, and Radiopharma.
Stock view
The shares last changed hands at EUR 13.13 on August 26, 2026, with a market cap of EUR 824.76 million and a 52-week range of EUR 12.97 to EUR 18.77. The stock remains below the recent analyst target of EUR 23.
Fact box
Company: Eckert & Ziegler SE
ISIN: DE0005659700
Ticker: EUZ
Exchange: Tradegate, XETRA
Price (as of August 26, 2026, 12:29 p.m. ET): EUR 13.13
Market cap: EUR 824.76 million (as of August 26, 2026)
Sector / Industry: Medical technology
Index membership: TecDAX, SDAX
Next earnings date: November 12, 2026
